# AbbVie to acquire West Pharmaceutical's Tempe manufacturing facility

AbbVie agreed to acquire a device manufacturing facility in Tempe, Arizona from West Pharmaceutical Services, planning to hire ~200 employees and invest over $175 million to modernize the site.

- Type: Acquisition
- Announced: 2026-01-12
- Where: Tempe, Arizona, United States
- Value: $175.0M
- Jobs: 200
- Status: announced
- Products: drug delivery devices, on-body injectors
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [West Pharmaceutical Services](https://endata.com/companies/7983.md) (partner)
- [AbbVie](https://endata.com/companies/29401.md) (acquirer)

## Sources

- [barchart.com](https://www.barchart.com/press-releases/36993213/abbvie-to-acquire-arizona-manufacturing-facility-further-strengthening-manufacturing-capabilities-in-the-united-states), 2026-01-12: "AbbVie (NYSE: ABBV) and West Pharmaceutical Services (NYSE: WST) announced today a definitive agreement for AbbVie to acquire a device manufacturing facility in Tempe, Arizona and associated intellectual property from West."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.